Acne and obesity: A nationwide study of 600,404 adolescents.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 17 11 2018
revised: 22 03 2019
accepted: 03 04 2019
pubmed: 13 4 2019
medline: 24 1 2020
entrez: 13 4 2019
Statut: ppublish

Résumé

The association between body mass index (BMI) and acne is unclear. To determine the association between BMI and acne in youths. A nationwide, population-based, cross-sectional study was conducted in 2002-2015 by using medical data on 600,404 youths during compulsory military service. BMI was measured at age 17 years. Acne was diagnosed by dermatologists. Unadjusted and adjusted odds ratios (aORs) of acne in relation to BMI (stratified into 8 groups) were calculated, with the low-normal group (18.5≤ BMI ≤21.99 kg/m The study included 299,163 males (49.9%) and 301,241 females (50.1%) with a mean age of 18.9 years (standard deviation, 0.6) and 18.7 years (standard deviation, 0.5), respectively, at recruitment. Acne was diagnosed in 55,842 males (18.7%) and 48,969 females (16.3%). The proportion of participants with acne decreased gradually from the underweight to the severely obese group (males, from 19.9% to 13.9%; females, from 16.9% to 11.3%). The findings on multivariable analysis were similar to the unadjusted analysis results, showing the lowest odds of acne in severely obese participants (aOR for males, 0.53; 95% confidence interval, 0.42-0.64; aOR for females, 0.5; 95% confidence interval, 0.37-0.62). The findings persisted in the sensitivity analyses. Information was lacking on potential confounders and acne severity. In youths, overweight and obesity are inversely associated with acne in a dose-dependent manner.

Sections du résumé

BACKGROUND BACKGROUND
The association between body mass index (BMI) and acne is unclear.
OBJECTIVE OBJECTIVE
To determine the association between BMI and acne in youths.
METHODS METHODS
A nationwide, population-based, cross-sectional study was conducted in 2002-2015 by using medical data on 600,404 youths during compulsory military service. BMI was measured at age 17 years. Acne was diagnosed by dermatologists. Unadjusted and adjusted odds ratios (aORs) of acne in relation to BMI (stratified into 8 groups) were calculated, with the low-normal group (18.5≤ BMI ≤21.99 kg/m
RESULTS RESULTS
The study included 299,163 males (49.9%) and 301,241 females (50.1%) with a mean age of 18.9 years (standard deviation, 0.6) and 18.7 years (standard deviation, 0.5), respectively, at recruitment. Acne was diagnosed in 55,842 males (18.7%) and 48,969 females (16.3%). The proportion of participants with acne decreased gradually from the underweight to the severely obese group (males, from 19.9% to 13.9%; females, from 16.9% to 11.3%). The findings on multivariable analysis were similar to the unadjusted analysis results, showing the lowest odds of acne in severely obese participants (aOR for males, 0.53; 95% confidence interval, 0.42-0.64; aOR for females, 0.5; 95% confidence interval, 0.37-0.62). The findings persisted in the sensitivity analyses.
LIMITATIONS CONCLUSIONS
Information was lacking on potential confounders and acne severity.
CONCLUSION CONCLUSIONS
In youths, overweight and obesity are inversely associated with acne in a dose-dependent manner.

Identifiants

pubmed: 30978426
pii: S0190-9622(19)30589-4
doi: 10.1016/j.jaad.2019.04.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

723-729

Informations de copyright

Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Igor Snast (I)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Medical Corps, Israel Defense Forces and Department of Military Medicine, Faculty of Medicine, the Hebrew University, Jerusalem, Israel. Electronic address: snastigor@gmail.com.

Adam Dalal (A)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Gilad Twig (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Medical Corps, Israel Defense Forces and Department of Military Medicine, Faculty of Medicine, the Hebrew University, Jerusalem, Israel; Department of Medicine, Sheba Medical Center, Tel-Hashomer, Israel; The Dr Pinchas Bornstein, Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel.

Nadav Astman (N)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Israel.

Ron Kedem (R)

Medical Corps, Israel Defense Forces and Department of Military Medicine, Faculty of Medicine, the Hebrew University, Jerusalem, Israel.

Dan Levin (D)

Medical Corps, Israel Defense Forces and Department of Military Medicine, Faculty of Medicine, the Hebrew University, Jerusalem, Israel.

Yifat Erlich (Y)

Medical Corps, Israel Defense Forces and Department of Military Medicine, Faculty of Medicine, the Hebrew University, Jerusalem, Israel.

Yael Anne Leshem (YA)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moshe Lapidoth (M)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Emmilia Hodak (E)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Assi Levi (A)

Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH